About Allogene: Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T) products for cancer and autoimmune disease. Led by a management team with significant experience in cell therapy, Allogene is developing a pipeline of off-the-shelf CAR T cell product candidates with the goal of delivering readily available cell therapy on-demand, more reliably, and at greater scale to more patients. About the role: Reporting to the General Counsel, the Senior Counsel, Corporate, Securities & Transactions will work closely with the General Counsel on Allogene's public company corporate legal function, including SEC reporting, corporate governance, Board and committee matters, proxy and annual meeting processes, Section 16 reporting, and related disclosure and compliance matters. The role will also support strategic transactions, business development activities, M&...